We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
First Bancorp
FBP
$4.43B
| $1.4M | ﹤0.01% |
108,557
-44,654
| -29% | -$611K |
|
1277
Insight Enterprises
NSIT
$4.43B
| $1.4M | ﹤0.01% |
16,232
+773
| +5% | +$75.5K |
|
1278
Dillards
DDS
$10.1B
| $1.39M | ﹤0.01% |
6,296
-608
| -9% | -$175K |
|
1279
Duluth Holdings
DLTH
$152M
| $1.39M | ﹤0.01% |
145,465
+2,491
| +2% | +$29K |
|
1280
Southwest Gas
SWX
$6.63B
| $1.38M | ﹤0.01% |
16,046
-46,867
| -74% | -$4.14M |
|
1281
Mercantile Bank Corp
MBWM
$1.05B
| $1.38M | ﹤0.01% |
43,187
+5,964
| +16% | +$193K |
|
1282
Movado Group
MOV
$822M
| $1.38M | ﹤0.01% |
44,617
+4,669
| +12% | +$164K |
|
1283
Banc of California
BANC
$3.09B
| $1.38M | ﹤0.01% |
78,276
+11,303
| +17% | +$206K |
|
1284
CorVel
CRVL
$3.09B
| $1.38M | ﹤0.01% |
28,062
+381
| +1% | +$19.6K |
|
1285
Certara
CERT
$1.24B
| $1.38M | ﹤0.01% |
65,978
+5,819
| +10% | +$115K |
|
1286
Kinsale Capital Group
KNSL
$8.53B
| $1.38M | ﹤0.01% |
6,246
-7,820
| -56% | -$1.73M |
|
|
MTOR
1287
DELISTED
MERITOR, Inc.
MTOR
| $1.37M | ﹤0.01% |
37,832
-22,490
| -37% | -$809K |
|
1288
Par Pacific Holdings
PARR
$3.78B
| $1.37M | ﹤0.01% |
88,076
-35,871
| -29% | -$565K |
|
1289
Palo Alto Networks
PANW
$313B
| $1.37M | ﹤0.01% |
16,944
+6,114
| +56% | +$542K |
|
|
SWAV
1290
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $1.37M | ﹤0.01% |
7,150
-10,692
| -60% | -$1.89M |
|
1291
First Internet Bancorp
INBK
$256M
| $1.35M | ﹤0.01% |
36,714
+27,177
| +285% | +$1.05M |
|
1292
Regional Management Corp
RM
$292M
| $1.35M | ﹤0.01% |
36,185
+2,877
| +9% | +$127K |
|
1293
Entravision Communication
EVC
$850M
| $1.35M | ﹤0.01% |
295,896
+145,960
| +97% | +$749K |
|
1294
Collegium Pharmaceutical
COLL
$843M
| $1.33M | ﹤0.01% |
75,227
+40,806
| +119% | +$686K |
|
|
RDUS
1295
DELISTED
Radius Recycling
RDUS
| $1.33M | ﹤0.01% |
40,597
+15,685
| +63% | +$669K |
|
1296
Peabody Energy
BTU
$2.98B
| $1.33M | ﹤0.01% |
62,352
-33,075
| -35% | -$812K |
|
1297
HealthStream
HSTM
$829M
| $1.33M | ﹤0.01% |
61,237
-13,433
| -18% | -$268K |
|
|
GMS
1298
DELISTED
GMS Inc
GMS
| $1.32M | ﹤0.01% |
29,757
-7,364
| -20% | -$349K |
|
1299
Children's Place
PLCE
$56.3M
| $1.32M | ﹤0.01% |
33,940
+11,334
| +50% | +$533K |
|
|
ALEX
1300
DELISTED
Alexander & Baldwin
ALEX
| $1.32M | ﹤0.01% |
73,563
-15,718
| -18% | -$324K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.